Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand

View ORCID ProfileAlana L. Whitcombe, View ORCID ProfileReuben McGregor, View ORCID ProfileAlyson Craigie, View ORCID ProfileAlex James, Richard Charlewood, View ORCID ProfileNatalie Lorenz, James M.J. Dickson, Campbell R. Sheen, Barbara Koch, Shivani Fox-Lewis, Gary McAuliffe, Sally A. Roberts, Susan C. Morpeth, Susan Taylor, Rachel H. Webb, Susan Jack, Arlo Upton, View ORCID ProfileJames Ussher, View ORCID ProfileNicole J. Moreland
doi: https://doi.org/10.1101/2020.12.10.20246751
Alana L. Whitcombe
1Faculty of Medical and Health Sciences, University of Auckland, New Zealand
2Maurice Wilkins Centre, University of Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alana L. Whitcombe
Reuben McGregor
1Faculty of Medical and Health Sciences, University of Auckland, New Zealand
2Maurice Wilkins Centre, University of Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Reuben McGregor
Alyson Craigie
3Southern Community Laboratories, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alyson Craigie
Alex James
4Te Punaha Matatini and School of Mathematics and Statistics, University of Canterbury, Christchurch, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex James
Richard Charlewood
5New Zealand Blood Service, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Lorenz
1Faculty of Medical and Health Sciences, University of Auckland, New Zealand
2Maurice Wilkins Centre, University of Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie Lorenz
James M.J. Dickson
6School of Biological Sciences, University of Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Campbell R. Sheen
7Protein Science and Engineering, Callaghan Innovation, Christchurch, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Koch
7Protein Science and Engineering, Callaghan Innovation, Christchurch, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivani Fox-Lewis
8LabPLUS, Auckland City Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary McAuliffe
8LabPLUS, Auckland City Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally A. Roberts
2Maurice Wilkins Centre, University of Auckland, New Zealand
8LabPLUS, Auckland City Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan C. Morpeth
9Middlemore Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Taylor
9Middlemore Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel H. Webb
1Faculty of Medical and Health Sciences, University of Auckland, New Zealand
2Maurice Wilkins Centre, University of Auckland, New Zealand
10Starship Children’s Hospital and Kidz First Children’s Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Jack
11Public Health South, Southern District Health Board, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arlo Upton
3Southern Community Laboratories, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Ussher
2Maurice Wilkins Centre, University of Auckland, New Zealand
3Southern Community Laboratories, Dunedin, New Zealand
13Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James Ussher
Nicole J. Moreland
1Faculty of Medical and Health Sciences, University of Auckland, New Zealand
2Maurice Wilkins Centre, University of Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicole J. Moreland
  • For correspondence: n.moreland@auckland.ac.nz
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Circulating antibodies are important markers of previous infection and immunity. Questions remain with respect to the durability and functionality of SARS-CoV-2 antibodies. This study explored antibody responses in recovered COVID-19 patients in a setting where the probability of re-exposure is effectively nil, owing to New Zealand’s successful elimination strategy.

Methods A triplex bead-based assay that detects antibody isotype (IgG, IgM and IgA) and subclass (IgG1, IgG2, IgG3, IgG4) responses against Nucleocapsid (N) protein, Receptor Binding Domain (RBD) and Spike (S) protein of SARS-CoV-2 was developed. After establishing baseline levels with pre-pandemic control sera (n=113), samples from PCR-confirmed COVID-19 patients with mild-moderate disease (n=189) collected up to eight months post-infection were examined. The relationship between antigen-specific antibodies and neutralising antibodies (NAbs) was explored with a surrogate neutralisation assay that quantifies inhibition of the RBD/hACE-2 interaction.

Results While most individuals had broad isotype and subclass responses to each antigen shortly after infection, only RBD and S protein IgG, as well as NAbs, were stable over the study period, with 99%, 96% and 90% of samples, respectively, having responses over baseline 4-8 months post-infection. Anti-RBD antibodies were strongly correlated with NAbs at all time points (Pearson’s r ≥ 0.87) and feasibility of using finger prick sampling to accurately measure anti-RBD IgG was demonstrated.

Conclusion Antibodies to SARS-CoV-2 persist for up to eight months following mild to moderate infection. This robust response can be attributed to the initial exposure without immune boosting given the lack of community transmission in our setting.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the School of Medicine Foundation (University of Auckland) and the COVID-19 Innovation Acceleration Fund (Ministry of Business, Innovation and Employment).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Health and Disability Ethics Committees New Zealand

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available on request from the corresponding author, NM, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted December 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand
Alana L. Whitcombe, Reuben McGregor, Alyson Craigie, Alex James, Richard Charlewood, Natalie Lorenz, James M.J. Dickson, Campbell R. Sheen, Barbara Koch, Shivani Fox-Lewis, Gary McAuliffe, Sally A. Roberts, Susan C. Morpeth, Susan Taylor, Rachel H. Webb, Susan Jack, Arlo Upton, James Ussher, Nicole J. Moreland
medRxiv 2020.12.10.20246751; doi: https://doi.org/10.1101/2020.12.10.20246751
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand
Alana L. Whitcombe, Reuben McGregor, Alyson Craigie, Alex James, Richard Charlewood, Natalie Lorenz, James M.J. Dickson, Campbell R. Sheen, Barbara Koch, Shivani Fox-Lewis, Gary McAuliffe, Sally A. Roberts, Susan C. Morpeth, Susan Taylor, Rachel H. Webb, Susan Jack, Arlo Upton, James Ussher, Nicole J. Moreland
medRxiv 2020.12.10.20246751; doi: https://doi.org/10.1101/2020.12.10.20246751

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10771)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1452)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)